Question 1

What is MS-DRG 848?

Accepted Answer

MS-DRG 848 is a Medicare Severity Diagnosis Related Group for "CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC". DRGs are used by Medicare to classify hospital cases into groups for payment purposes. Each DRG has a payment weight based on the average resources used to treat patients in that group.

Question 2

How many hospitalizations were there for CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC in 2023?

Accepted Answer

There were 114 Medicare hospitalizations classified under MS-DRG 848 in 2023. This represents a -8.1% change from 2022.

Question 3

What is the average cost for CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC?

Accepted Answer

The average hospital charges for MS-DRG 848 were $36,862 in 2023. Note that charges represent what hospitals bill, which is typically higher than what Medicare actually pays.

Question 4

How have hospitalizations for this DRG changed over time?

Accepted Answer

Medicare hospitalization data for MS-DRG 848 is available from 2013 to 2023. The charts above show the historical trends in hospitalizations and average charges over this period.